Rocket Lab USA, Inc. (RKLB)
NASDAQ · Industrials · Aerospace & Defense
Profile
Rocket Lab USA, Inc.
- Exchange
- NASDAQ
- Ticker
- RKLB
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Country
- US
Headquartered in Long Beach, California, Rocket Lab USA, Inc. is a prominent aerospace firm established in 2006. This company delivers a comprehensive suite of space-related services and hardware, primarily catering to the space and defense industries. Their operations encompass orbital launch capabilities, advanced spacecraft engineering and construction, production of various spacecraft components, and sophisticated on-orbit management services, including full constellation management. Rocket Lab is known for developing and producing a range of launch vehicles, from small to medium-class rockets. Key products include the highly successful Electron small orbital launch vehicle and the versatile Photon satellite platforms, both of which they design, manufacture, and market. Furthermore, the company is actively developing the larger Neutron launch vehicle, capable of carrying 8-ton payloads. Beyond manufacturing, they also conduct remote launch operations and craft specialized components and subsystems for both their Photon spacecraft family and the broader commercial spacecraft market. Their diverse clientele spans commercial enterprises, major aerospace contractors, and governmental entities.
Key facts
Rocket Lab USA, Inc.: key facts
- Rocket Lab USA, Inc. (NASDAQ: RKLB) is a Aerospace & Defense company in the Industrials sector.
- In fiscal 2025, Rocket Lab USA, Inc. reported revenue of $601.8M and net income of -$198.2M.
- Revenue grew 76.3% a year over the last 4 fiscal years.
- Free cash flow was positive in 0 of the last 5 fiscal years.
- Net income was positive in 0 of the last 5 fiscal years.
- Over the last twelve months, revenue was $769.1M and net income was -$165.5M.
MonkScore
Rocket Lab USA, Inc.'s MonkScore
MonkScore
MonkScore range: 0–10
as of October 2026
Sector rank: 1306 of 1409 in Industrials
How this score is madeDisclaimer
Pillar ranges
- Growth50–60
- Profitability10–20
- Quality10–20
- Market Conviction90–100
- Safety0–10
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Rocket Lab USA, Inc.'s annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $769.1M | $601.8M | $436.2M | $244.6M | $211.0M | $62.2M |
| Gross profit | $286.6M | $207.2M | $116.1M | $51.4M | $19.0M | -$1.9M |
| Operating income | -$223.5M | -$228.8M | -$189.8M | -$177.9M | -$135.2M | -$102.1M |
| Net income | -$165.5M | -$198.2M | -$190.2M | -$182.6M | -$135.9M | -$117.3M |
| Operating cash flow | -$222.5M | -$165.5M | -$48.9M | -$98.9M | -$106.5M | -$71.8M |
| Capital expenditure | -$148.7M | -$156.3M | -$67.1M | -$54.7M | -$42.4M | -$25.7M |
| Free cash flow | -$371.1M | -$321.8M | -$116.0M | -$153.6M | -$149.0M | -$97.5M |
| Total debt | $133.7M | $254.0M | $468.4M | $176.7M | $152.8M | $128.4M |
| Cash | $2.1B | $828.7M | $271.0M | $162.5M | $242.5M | $691.0M |
Revenue growth a year
- 1-year
- 38.0%
- 3-year
- 41.8%
- 4-year
- 76.3%
Compound growth between fiscal years.
Peers
Similar companies
- Kratos Defense & Security Solutions, Inc.NASDAQ:KTOSMonkScore range: 10–20
- Sturm, Ruger & Company, Inc.NYSE:RGRMonkScore range: 10–20
- Huntington Ingalls Industries, Inc.NYSE:HIIMonkScore range: 10–20
- Textron Inc.NYSE:TXTMonkScore range: 10–20
- TAT Technologies Ltd.NASDAQ:TATTMonkScore range: 10–20
- VSE CorporationNASDAQ:VSECMonkScore range: 20–30
- Ducommun IncorporatedNYSE:DCOMonkScore range: 20–30
- V2X, Inc.NYSE:VVXMonkScore range: 20–30
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.